MaxCyte Inc.
MaxCyte Inc. (MXCT): ~39 mo cash runway. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
39.3 months
D/E 0.16 · 0% dilution
N/A
N/A
N/A
0 buys · 1 sell (180d)
A transparent, data-derived signal for MaxCyte Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$124.3M
Cash
$14.6M
Quarterly Burn
$8.2M
Runway
39.3 mo
Revenue
$9.7M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
127
Total value held
$38.9M
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 8,798,473 | $6.2M |
| vanguard capital management llc | 7,963,632 | $5.6M |
| vitruvian partners llp | 5,043,356 | $3.5M |
| morgan stanley | 3,688,131 | $2.6M |
| bnp paribas asset management holding s.a. | 2,773,554 | $1.9M |
| geode capital management, llc | 2,362,672 | $1.7M |
| state street corp | 2,193,470 | $1.5M |
| renaissance technologies llc | 1,993,200 | $1.4M |
| cadian capital management, lp | 1,722,942 | $1.2M |
| peapod lane capital llc | 1,332,193 | $926K |
Showing top 10 of 127 institutional holders of MaxCyte Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
What is MaxCyte Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, MaxCyte Inc. has approximately 39.3 months of cash runway.
What is MaxCyte Inc.'s market capitalization?
MaxCyte Inc.'s market capitalization is approximately $124.3M.
Who is the CEO of MaxCyte Inc.?
Mr. Maher Masoud is the chief executive officer of MaxCyte Inc. (MXCT).
Get the full picture on MaxCyte Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.